strate labs semaglutide (GLP-1) Research Peptide Why Strate Labs Is Closing

Drugs with indication and recent clinical evidence The pathophysiology of MASLD and MASH integrates insulin resistance, lipotoxicity, inflammation, and fibrogenic remodeling

The 29-gauge hits the sweet spot between comfort and function for most body types

Compounded GLP-1 Therapies Compounded medications: Are not FDA-approved Do not undergo FDA premarket review for safety, effectiveness, or manufacturing quality May only be prepared when a licensed prescriber determines there is a clinically significant difference needed for an identified patient Compounded medications are not FDA-approved and do not undergo FDA review for safety, effectiveness, or manufacturing quality

A responsible evaluation starts with your goals and your full health picture, not with a compound